Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Human UDP-glucuronosyltransferase 1A5: identification, expression, and activity.

Moshe Finel1, Xin Li, Dione Gardner-Stephen

  • 1Viikki DDTC, Faculty of Pharmacy, University of Helsinki, P.O. Box 56 (Viikinkaari 5E), 00014 University of Helsinki, Finland. moshe.finel@helsinki.fi

The Journal of Pharmacology and Experimental Therapeutics
|August 27, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

`3-Hydroxy-6H,7H-chromeno [3,4-c]chromene-6,7-dione as a Substrate for Studying Glucuronidation, Sulfonation and Lactone Hydrolysis.

Drug metabolism and bioanalysis letters·2026
Same author

UDP-glucuronosyltransferase 1A9 function is mediated by the two C-terminal lysine residues and proper mobility/flexibility of the cytoplasmic tail.

Biochemical and biophysical research communications·2025
Same author

Disulfide bond-mediated stabilization of the oligomers of UDP-glucuronosyltransferase 2B7.

The Journal of biological chemistry·2025
Same author

Sex-specific UGT expression and function: prevalence, potential mechanisms and significance.

Expert opinion on drug metabolism & toxicology·2025
Same author

Efflux and uptake of androgen sulfates using transporter-overexpressing HEK293 cells and membrane vesicles.

Journal of pharmaceutical sciences·2025
Same author

Genome-wide analyses of neonatal jaundice reveal a marked departure from adult bilirubin metabolism.

Nature communications·2024

This study confirms human UDP-glucuronosyltransferase 1A5 (UGT1A5) is expressed in various tissues, is inducible by drugs, and shows catalytic activity. Researchers found UGT1A5 in liver and intestine, with levels varying between individuals.

Area of Science:

  • Pharmacogenomics
  • Drug metabolism
  • Enzymology

Background:

  • The human UDP-glucuronosyltransferase (UGT) subfamily 1A comprises nine genes.
  • Expression of UGT1A isoforms, except UGT1A5, has been previously documented.

Purpose of the Study:

  • To investigate the expression, inducibility, and catalytic activity of the human UGT1A5 gene.
  • To characterize the substrate specificity of the UGT1A5 enzyme.

Main Methods:

  • Detection of UGT1A5 mRNA in cultured human hepatocytes, HepG2, Caco-2 cells, and human liver and intestinal tissues.
  • Induction studies using rifampicin and 3-methylcholanthrene.
  • Isolation of full-length UGT1A5 cDNA and recombinant protein expression.
  • Enzymatic assays using various substrates (4-methylumbelliferone, scopoletin, 1-hydroxypyrene, 4-aminobiphenyl).

Related Experiment Videos

  • Site-directed mutagenesis to investigate substrate binding.
  • Main Results:

    • Low basal UGT1A5 expression detected in cultured human hepatocytes, HepG2, Caco-2 cells, and human liver.
    • UGT1A5 mRNA levels increased upon treatment with rifampicin or 3-methylcholanthrene.
    • UGT1A5 expression found in various human intestinal segments with significant interindividual variability.
    • Recombinant UGT1A5 showed low activity for 4-methylumbelliferone and scopoletin but higher activity for 1-hydroxypyrene.
    • UGT1A5 did not glucuronidate 4-aminobiphenyl; mutagenesis studies did not alter this activity.

    Conclusions:

    • The human UGT1A5 gene is expressed in multiple tissues, including the liver and intestine.
    • UGT1A5 expression is inducible by xenobiotics.
    • The UGT1A5 enzyme is catalytically active, with specific substrate preferences, and plays a role in drug metabolism.